Zobrazeno 1 - 10
of 57
pro vyhledávání: '"D R, Parkinson"'
Autor:
M. Shiraki, John S.J. Brooks, Louise Ryan, Ronald H. Blum, D. R. Parkinson, Stephen Frytak, John H. Edmonson
Publikováno v:
Journal of Clinical Oncology. 11:1269-1275
PURPOSE This three-armed phase III study in adults with advanced soft tissue sarcomas was planned as a comparison of objective regression rates, toxicity, and survival of patients receiving doxorubicin alone, ifosfamide plus doxorubicin, and mitomyci
Publikováno v:
Journal of Clinical Oncology. 9:2052-2066
Levamisole has been used in a wide array of clinical research and treatment settings over the past two decades, ranging from such diseases as helminthic infestations to various autoimmune diseases. Numerous preclinical evaluations and clinical trials
Autor:
G, Schwartsmann, M J, Ratain, G M, Cragg, J E, Wong, N, Saijo, D R, Parkinson, Y, Fujiwara, R, Pazdur, D J, Newman, R, Dagher, L, Di Leone
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20
This year's American Society of Clinical Oncology International Symposium devoted 2 hours to a lively discussion of various aspects of anticancer drug discovery and development throughout the world. The scientific program started with an overview of
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The cancer journal from Scientific American. 3
This article updates response duration and survival data for patients with metastatic renal cell carcinoma receiving high-dose recombinant interleukin-2 (rIL-2).Two hundred fifty-five assessable renal cell carcinoma patients were entered into seven p
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 21(1)
Recent advances in the understanding of the mechanisms leading to tumor recognition by the immune system have shown that, at least in the case of human melanoma, the majority of cytotoxic T lymphocytes (CTL) identified in association with in vivo tum
Autor:
P T, Ho, D R, Parkinson
Publikováno v:
Seminars in oncology. 24(2)
The continued progress in our understanding of the biology of neoplasia and in the identification, cloning, and sequencing of genes critical to tumor cell function permits the exploitation of this information to develop specific agents that may direc
Autor:
J M, Pluda, D R, Parkinson
Publikováno v:
Cancer. 78
There is now a substantial body of evidence that tumor growth is angiogenesis-dependent, and that neovascularization is also necessary for tumor invasion and metastasis. In addition, the assessment of microvessel count or density in a primary tumor m
Autor:
R E, Royal, S M, Steinberg, R S, Krouse, G, Heywood, D E, White, P, Hwu, F M, Marincola, D R, Parkinson, D J, Schwartzentruber, S L, Topalian, J C, Yang, S A, Rosenberg
Publikováno v:
The cancer journal from Scientific American. 2(2)
We evaluated the characteristics of patients with metastatic renal cancer or metastatic melanoma prior to and during treatment with bolus intravenous interleukin-2 to define prognostic indicators of subsequent response to therapy.A consecutive series
Autor:
D R, Parkinson, M, Sznol
Publikováno v:
Seminars in oncology. 22(1)